Market Overview - The cosmetics sector increased by 0.2% on November 13, with Jinsheng New Materials leading the gains [1] - The Shanghai Composite Index closed at 4029.5, up 0.73%, while the Shenzhen Component Index closed at 13476.52, up 1.78% [1] Individual Stock Performance - Jinsheng New Materials (300849) closed at 16.16, up 2.08% with a trading volume of 59,500 shares and a transaction value of 95.82 million yuan [1] - Shuiyang Co. (300740) closed at 21.51, up 2.04% with a trading volume of 147,200 shares and a transaction value of 314 million yuan [1] - Beitaini (300957) closed at 43.24, up 1.08% with a trading volume of 35,900 shares and a transaction value of 154 million yuan [1] - Other notable stocks include Furuida (600223) at 7.98 (+0.63%), Qingsong Co. (300132) at 8.12 (+0.37%), and Qingdao Kingway (002094) at 7.80 (+0.26%) [1] Capital Flow Analysis - The cosmetics sector experienced a net outflow of 56.57 million yuan from institutional investors and 32.11 million yuan from retail investors, while individual investors saw a net inflow of 88.67 million yuan [2] - The capital flow for individual stocks shows that Shuiyang Co. had a net inflow of 21.64 million yuan from institutional investors, while other stocks like Huaye Fragrance (300886) and Kesheng Co. (300856) faced net outflows [3]

Core Viewpoint - The cosmetics sector experienced a notable increase of 3.13% on November 10, with Lafang Jiahua leading the gains [1] Group 1: Market Performance - The Shanghai Composite Index closed at 4018.6, up 0.53%, while the Shenzhen Component Index closed at 13427.61, up 0.18% [1] - Lafang Jiahua's stock price rose by 6.14% to 23.51, with a trading volume of 96,700 shares and a transaction value of 223 million [1] - Other notable performers included: - Jiahen Jiahua: 5.57% increase, closing at 36.79 with a transaction value of 124 million [1] - Qingsong Co.: 4.56% increase, closing at 7.80 with a transaction value of 362 million [1] - Proya: 4.46% increase, closing at 73.32 with a transaction value of 759 million [1] Group 2: Fund Flow Analysis - The cosmetics sector saw a net inflow of 152 million from institutional investors, while retail investors experienced a net outflow of 179 million [1] - Key fund flows for selected companies included: - Lafang Jiahua: 22.32 million net inflow from institutional investors, with a net outflow of 11.42 million from retail investors [2] - Beitaini: 34.32 million net inflow from institutional investors, with a net outflow of 13.48 million from retail investors [2] - Shanghai Jahwa: 24.72 million net inflow from institutional investors, with a net outflow of 30.62 million from retail investors [2]

Market Overview - The cosmetics sector experienced a decline of 1.21% on November 6, with Betaini leading the drop [1] - The Shanghai Composite Index closed at 4007.76, up 0.97%, while the Shenzhen Component Index closed at 13452.42, up 1.73% [1] Individual Stock Performance - Notable gainers included: - Shuiyang Co., Ltd. (300740) with a closing price of 20.83, up 1.46% [1] - Qingsong Co., Ltd. (300132) with a closing price of 7.27, up 1.11% [1] - Significant decliners included: - Betaini (300957) with a closing price of 42.22, down 4.89% [2] - Jiahen Home Care (300955) with a closing price of 36.68, down 3.47% [2] Trading Volume and Capital Flow - The cosmetics sector saw a net outflow of 82.6352 million yuan from institutional investors, while retail investors had a net inflow of 58.2199 million yuan [2] - The trading volume for Shuiyang Co., Ltd. was 149,100 shares, with a transaction value of 311 million yuan [1] Capital Flow Analysis - Major net inflows were observed in: - Shuiyang Co., Ltd. with a net inflow of 23.1839 million yuan [3] - Qingsong Co., Ltd. with a net inflow of 7.1227 million yuan [3] - Major net outflows were noted in: - Betaini with a net outflow of 90.237 million yuan [3] - Shanghai Jahwa (600315) with a net outflow of 90.237 million yuan [3]

Core Viewpoint - The cosmetics sector experienced a decline of 1.75% on November 4, with Marubi Biotechnology leading the drop [1][2] Group 1: Market Performance - The Shanghai Composite Index closed at 3960.19, down 0.41%, while the Shenzhen Component Index closed at 13175.22, down 1.71% [1] - Major stocks in the cosmetics sector showed varied performance, with Qing Song Co. slightly up by 0.28% and Marubi Biotechnology down by 3.92% [1][2] Group 2: Trading Volume and Value - The trading volume and value for key stocks in the cosmetics sector were significant, with Qingdao Kingway recording a trading volume of 576,600 shares and a transaction value of 470 million yuan [2] - The total net outflow of main funds in the cosmetics sector was 208 million yuan, while retail investors saw a net inflow of 155 million yuan [2] Group 3: Fund Flow Analysis - The main funds showed a net outflow in several companies, including Marubi Biotechnology with a net outflow of 7.54 million yuan, while retail investors had a net inflow of 17.24 million yuan [3] - LaFang Co. had a net inflow of 8.17 million yuan from retail investors, despite a net outflow from main funds [3]

Market Overview - The cosmetics sector increased by 0.77% on October 29, with Marubi Biological leading the gains [1] - The Shanghai Composite Index closed at 4016.33, up 0.7%, while the Shenzhen Component Index closed at 13691.38, up 1.95% [1] Individual Stock Performance - Marubi Biological (603983) closed at 36.66, up 3.74% with a trading volume of 41,500 shares and a turnover of 150 million yuan [1] - Babi Co. (920123) closed at 18.06, up 3.56% with a trading volume of 23,700 shares and a turnover of 41.72 million yuan [1] - Shanghai Jahwa (600315) closed at 25.46, up 2.74% with a trading volume of 154,500 shares and a turnover of 392 million yuan [1] - Betaini (300957) closed at 45.83, up 0.57% with a trading volume of 33,400 shares and a turnover of 152 million yuan [1] - Other notable performances include Proya (603605) at 76.87, up 0.18%, and Water Sheep Co. (300740) at 22.14, up 0.09% [1] Fund Flow Analysis - The cosmetics sector experienced a net outflow of 89.37 million yuan from institutional investors and 51.47 million yuan from retail investors, while individual investors saw a net inflow of 141 million yuan [2] - The detailed fund flow for individual stocks shows that Shanghai Jahwa had a net outflow of 32.36 million yuan from institutional investors [3] - Marubi Biological had a net inflow of 4.95 million yuan from institutional investors, but a net outflow of 8.77 million yuan from retail investors [3]

Core Viewpoint - Jinsong New Materials is a leading domestic supplier of cosmetic plastic packaging containers, with strong R&D and production capabilities, and has been publicly listed since July 2020 [1] Group 1: Business Performance - For Q3 2025, Jinsong New Materials reported revenue of 238 million, ranking 7th among 7 companies in the industry, with the industry leader, Qingsong Co., achieving 1.553 billion in revenue [2] - The main business revenue composition includes injection molded products at 144 million (95.42%), glass bottles at 3.9189 million (2.60%), and molds at 3.0023 million (1.99%) [2] - The net profit for the same period was -9.4719 million, ranking 6th in the industry, with the industry leader's net profit at 107 million [2] Group 2: Financial Ratios - As of Q3 2025, Jinsong New Materials had a debt-to-asset ratio of 15.99%, down from 18.42% year-on-year, significantly lower than the industry average of 36.05%, indicating good solvency [3] - The gross profit margin for the period was 19.75%, up from 18.83% year-on-year, but still below the industry average of 21.95% [3] Group 3: Executive Compensation - The chairman, Ruan Rongtao, received a salary of 579,800, an increase of 5,500 from the previous year [4] - The general manager, Ruan Qijiang, earned 497,300, up by 5,900 from the previous year [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 13.27% to 8,200, while the average number of circulating A-shares held per household increased by 15.30% to 14,800 [5]

Core Viewpoint - Jinsheng New Materials (300849.SZ) reported a decline in revenue and incurred a net loss in the first three quarters of 2025 [1] Financial Performance - The company's revenue for the first three quarters was 238 million yuan, representing a year-on-year decrease of 8.41% [1] - The net loss attributable to shareholders of the listed company was 9.4719 million yuan [1] - The net loss attributable to shareholders, excluding non-recurring gains and losses, was 12.6701 million yuan [1] - The basic loss per share was 0.0631 yuan [1]

Group 1 - The core viewpoint of the news is that Jinsheng New Materials (SZ 300849) reported a decline in revenue and a net loss for the third quarter of 2025 [1] - For the first three quarters of 2025, the company's revenue was approximately 238 million yuan, representing a year-on-year decrease of 8.41% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 9.47 million yuan, with basic earnings per share showing a loss of 0.0631 yuan [1] Group 2 - As of the report, Jinsheng New Materials has a market capitalization of 2.2 billion yuan [2] - The A-share market has surpassed 4000 points, indicating a significant market resurgence after a decade of stagnation, with technology leading the market transformation [2]

一、 本次计提和转回信用减值准备及资产减值准备情况概述 证券代码：300849 证券简称：锦盛新材 公告编号：2025-041 浙江锦盛新材料股份有限公司 1、 本次计提和转回信用减值准备及资产减值准备的原因 为真实、客观地反映浙江锦盛新材料股份有限公司（以下简称"公司"） 的财务状况及资产价值，根据《企业会计准则》《深圳证券交易所创业板股票 上市规则》及公司会计政策的相关规定，本着谨慎性原则，对截至 2025 年 9 月 30 日合并报表范围内可能发生减值迹象的相关资产进行计提信用减值准备 及资产减值准备。 2、 本次计提和转回减值准备的资产范围和总金额 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 关于 2025 年前三季度计提和转回信用减值准备及资产减值准 备的公告 对于购买或源生的已发生信用减值的金融资产，公司在资产负债表日仅将 自初始确认后整个存续期内预期信用损失的累计变动确认为损失准备。 公司对合并报表范围内截至 2025 年 9 月 30 日可能发生减值迹象的资产 （范围包括应收款项、其他应收款、存货、合同资产、固定资产、长期股权投 资、无形资 ...

Financial Performance - The company's operating revenue for Q3 2025 was ¥86,530,491.10, a decrease of 6.77% compared to the same period last year[5] - The net profit attributable to shareholders was -¥675,343.51, representing a decline of 316.77% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥1,722,230.95, a significant drop of 3,510.78% compared to the previous year[5] - The company reported a net loss of -¥9,471,881.03 for the first nine months of 2025, a decline of 1,183.73% compared to the same period last year[11] - For the period from January to September 2025, the company achieved operating revenue of CNY 237.51 million, a decrease of 8.41% compared to the same period last year[13] - The net profit attributable to shareholders for the period was a loss of CNY 9.47 million, a decrease of 1183.73% year-on-year[13] - Net profit for the period was a loss of ¥9,471,881.03, compared to a profit of ¥874,009.84 in the previous period, indicating a significant decline[24] Assets and Liabilities - Total assets at the end of Q3 2025 were ¥701,419,689.12, down 4.23% from the end of the previous year[5] - Total assets decreased to ¥701,419,689.12 from ¥732,383,214.73, a decline of approximately 4.2%[22] - Total liabilities decreased to ¥112,137,433.38 from ¥133,629,077.96, a reduction of about 16.1%[22] - Non-current assets totaled ¥402,454,553.43, down from ¥434,855,168.08, reflecting a decrease of approximately 7.4%[22] - Current liabilities decreased to ¥103,447,924.60 from ¥123,740,061.16, a decline of about 16.4%[22] Cash Flow - The company's cash flow from operating activities for the first nine months of 2025 was ¥17,419,688.51, an increase of 1.67% year-on-year[12] - Operating cash flow for the current period is CNY 17,419,688.51, a slight increase from CNY 17,134,141.93 in the previous period, reflecting a stable operational performance[27] - Cash received from sales of goods and services was CNY 263,910,110.03, slightly down from CNY 266,379,116.69, suggesting a minor decline in sales revenue[27] - Total cash outflow from operating activities was CNY 249,832,948.32, down from CNY 252,749,665.83, indicating better cost management[27] - The company’s cash flow from operations remains positive, indicating ongoing operational viability despite fluctuations in other cash flow categories[27] Investment Activities - The net cash flow from investment activities decreased by 82.11% to ¥15,441,859.24, primarily due to changes in wealth management scale[12] - Total cash inflow from investment activities decreased to CNY 110,966,282.24 from CNY 162,104,945.87, indicating a reduction in investment recovery[28] - Net cash flow from investment activities dropped significantly to CNY 15,441,859.24 from CNY 86,325,013.57, highlighting a decline in investment returns[28] Regulatory Issues - The company received a notice from the China Securities Regulatory Commission regarding a suspected violation of information disclosure laws in June 2025[18] - The company and related parties received a warning letter from the Zhejiang Regulatory Bureau in September 2025 for regulatory measures taken against them[18] Shareholder Information - The top ten shareholders hold a combined 35.11% of the company's shares, with the largest shareholder, Ruan Rongtao, holding 20.32%[15] Other Financial Metrics - The overall gross profit margin for the same period was 19.75%, up from 18.83% in the previous year, reflecting a 0.92% increase[13] - Basic and diluted earnings per share were both -0.0631, down from 0.0058 in the previous period[26] - Financial expenses decreased by 64.70% to ¥460,316.11, mainly due to a reduction in financing scale[10] - The company experienced a 40.33% increase in other income to ¥3,346,425.36, primarily from government subsidies[10]